Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets is a research paper published in Leukemia (2023). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: R35HL135795
NCI NIH HHS
Grant: R01 CA217992
National Institutes of Health
Grant: 5R35HL135795-06
Therapeutic Implications of Molecular Defects in Bone Marrow Failure
FWCI
5.07
Citation Percentile
1.0%
Influential Citations
3
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Additional file 2 of Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Additional file 1 of Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Additional file 1 of Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients